Equities

IOL Chemicals and Pharmaceuticals Ltd

IOL Chemicals and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)399.50
  • Today's Change-0.85 / -0.21%
  • Shares traded175.23k
  • 1 Year change-3.15%
  • Beta1.3718
Data delayed at least 15 minutes, as of Apr 26 2024 11:28 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IOL Chemicals and Pharmaceuticals Limited is engaged in manufacturing and selling of pharmaceutical and chemical products. The Company operates through two segments: Chemical, and Pharmaceutical. The Chemical segment produces and sells Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride, Mono Chloro Acetic Acid, Para Amino Phenol (PAP), and others. The Pharmaceutical segment produces and sells various active pharma ingredients (API) include Ibuprofen, Metformin, Fenofibrate, Lamotrigine, Clopidogrel Bisulphate, Pantoprazole, Gabapentin, Paracetamol, and others. Its API product portfolio includes Ibuprofen, Metformin HCL, Pantoprazole Sodium, Clopidogrel Bisulphate (Form II), Lamotrigine, Losartan Potassium, Levetiracetam, Paracetamol, Fenofibrate (Micronised), and Gabapentin. Its Specialty Chemical division includes Ethyl Acetate, and Acetic Anhydride. Its Ethyl Acetate is used in industries like flexible packaging, pharmaceuticals, ink, food processing, pesticides, and paint industry.

  • Revenue in INR (TTM)22.16bn
  • Net income in INR1.72bn
  • Incorporated1986
  • Employees2.56k
  • Location
    IOL Chemicals and Pharmaceuticals Ltd85, Industrial Area, 'A',LUDHIANA 141003IndiaIND
  • Phone+91 1 612225531
  • Fax+91 1 612608784
  • Websitehttp://www.iolcp.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Kiri Industries Ltd8.99bn811.23m19.29bn949.0023.78--14.862.1515.6515.65173.44--------9,473,431.00--10.10--11.8525.6824.319.0221.11---------36.87-3.60-72.57-21.51-19.50--
Bhagiradha Chemicals and Industries Ltd4.19bn203.95m20.06bn467.00100.35--64.484.7919.2119.21388.90--------8,971,398.00--8.84--14.3838.8525.764.876.84--5.12----15.2521.8826.31--26.58--
Vishnu Chemicals Ltd12.48bn1.09bn20.30bn422.0017.50--14.461.6317.7017.70200.84--------29,577,610.00--7.30--12.9430.0535.318.736.53--4.62--2.8030.1216.3567.7856.7728.8614.87
Panama Petrochem Ltd.21.26bn1.85bn20.31bn156.0010.98--10.440.955330.5830.58351.50--------136,292,900.00--13.51--23.5417.0920.038.708.39--16.13--18.175.4610.811.1430.7513.7746.14
Madhya Bharat Agro products Ltd9.05bn477.43m21.09bn308.0044.17--27.592.335.455.45103.55--------29,386,250.00--15.18--22.3328.1734.915.2711.95--4.23--2.4099.8161.31117.8289.2734.2614.87
Gocl Corporation Ltd7.69bn570.72m21.25bn222.0037.23--30.822.7611.5211.52155.23--------34,656,330.00--4.51--5.3123.0127.617.4219.41---0.1333--17.8384.8413.1419.9144.00-1.0625.59
Yasho Industries Ltd5.73bn556.75m21.64bn659.0038.77--30.033.7748.9648.96504.09--------8,698,619.00--9.43--18.5136.0632.219.717.26--5.54--0.67359.6121.8729.8053.4755.03--
Sigachi Industries Ltd3.67bn494.13m21.91bn1.03k45.41--37.325.971.471.4711.07--------3,551,738.00--18.15--24.6352.7849.4313.4515.12--10.02--0.0020.6824.438.7449.6487.10--
Foseco India Ltd4.77bn729.83m23.10bn225.0031.668.0628.604.84114.28114.28747.54448.781.259.795.11--19.0913.7627.6219.8245.7139.2615.2911.352.59843.420.000832.9117.385.6858.7717.909.290.00
IOL Chemicals and Pharmaceuticals Ltd.22.16bn1.72bn23.45bn2.56k13.67--10.191.0629.2229.22377.38--------8,666,719.00--18.93--25.0734.4735.177.7413.56--12.39--7.621.5217.24-17.0238.1034.37--
Astec LifeSciences Limited4.31bn-509.39m23.92bn551.00------5.54-25.98-25.98220.09--------7,829,481.00--7.99--17.1330.4130.42-11.809.38---1.93--5.57-7.1511.12-71.55-6.0418.730.00
India Glycols Ltd74.98bn1.71bn26.01bn1.28k15.20--9.460.346955.2655.262,421.80--------58,398,440.00--3.79--6.6610.5610.732.282.71--2.85--12.440.60959.80-62.055.3227.6413.40
India Pesticides Ltd7.52bn891.33m27.33bn280.0030.56--26.463.637.777.7765.60--------26,866,790.00--------41.48--11.85----24.73----23.57---9.32------
Thirumalai Chemicals Ltd19.88bn-311.60m27.88bn526.00----88.571.40-3.04-3.04194.33--------37,785,930.00--8.76--12.1521.7128.27-1.578.27---0.4122--16.706.719.78-68.06-12.0243.84-5.59
Data as of Apr 26 2024. Currency figures normalised to IOL Chemicals and Pharmaceuticals Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

3.44%Per cent of shares held by top holders
HolderShares% Held
PineBridge Investments Asia Ltd.as of 31 Dec 20231.35m2.29%
Dimensional Fund Advisors LPas of 04 Apr 2024364.18k0.62%
Mellon Investments Corp.as of 04 Apr 2024162.88k0.28%
American Century Investment Management, Inc.as of 04 Apr 202445.17k0.08%
Motilal Oswal Asset Management Co. Ltd.as of 31 Mar 202434.55k0.06%
Dimensional Fund Advisors Ltd.as of 29 Feb 202429.10k0.05%
SSgA Funds Management, Inc.as of 04 Apr 202428.72k0.05%
DFA Australia Ltd.as of 31 Mar 20246.31k0.01%
Segall Bryant & Hamill LLCas of 31 Dec 20233.62k0.01%
Groww Asset Management Ltd.as of 31 Mar 2024154.000.00%
More ▼
Data from 31 Dec 2023 - 25 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.